Inforsense Reports Successful Application Of Knowledge Discovery Environment To Genetic Data Analysis

InforSense Ltd., the leading provider of Open Discovery Workflow informatics platforms, reports the successful application of its powerful Open Discovery Workflow™ technology for genetic data analysis.

In the recent paper “Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis” by Zheng Ye, Yike Guo, and H Song [J. Med. Genet., 2004; 41; 360-365], the InforSense 1.8 software was used to evaluate the hypothesis that the genes GSTM1 and GSTT1 encoding Glutathione S-Transferase (GST) isoforms are important risk factors for head and neck cancer. With the help of the InforSense Knowledge Discovery Environment, researchers were able to integrate very efficiently genomic and clinical data with statistical tools to streamline their analysis.

“Pharmacogenomic studies to identify individuals with increased risk of disease are becoming an increasingly important part of the drug development process,” commented Jonathan Sheldon, Chief Scientific Officer, Life Sciences at InforSense. “This work demonstrates the flexibility of InforSense technology to support such genetic analyses, notably the processing of clinical data for the purpose of patient stratification.”